View this email in your browser
Last Chance to Register!

PRI and the Pioneer Institute invite you to attend

Policy Measures on Drug Value:
Does ICER's Approach Improve Patient Access and Equity?

Webinar and discussion

Monday, July 19, 2021   ┃    9 am Pacific Time  /  12 pm Eastern 

JOIN US 
Monday, July 19
9-10 am Pacific / 12-1 pm Eastern
Zoom (Click here to download Zoom)
REGISTER NOW
PRI and the Pioneer Institute invite you attend an informative webinar on the policy landscape on treatment value and access and how policy proposals that lean on the Institute for Clinical and Economic Review (ICER) could impact patients, equity, and innovation.

Increasingly, federal and state lawmakers and regulators are looking to ICER and drug value assessment frameworks to determine drug access and pricing decisions. But not every drug pricing policy solution deserves merit – especially those that could threaten treatment access for underserved populations, jeopardize innovation, and ignore the perspective of patients who will be impacted by these policies. 

Join us on July 19 to hear scholars from PRI and Pioneer Institute, along with policy experts, advocates and special guests for a timely discussion on the policy landscape on treatment value and access and how policy proposals that lean on ICER could impact patients.
 
REGISTER NOW

Speakers

  • William “Bill” Smith, PhD, Visiting Fellow in Life Sciences, Pioneer Institute
  • Wayne Winegarden, Senior Fellow in Business & Economics, Pacific Research Institute 
  • Gary Puckrein, PhD, President & CEO, National Minority Quality Forum
  • Anna Hyde, Vice President of Advocacy & Access, Arthritis Foundation
  • Gunnar Esiason, Director of Patient Outreach, Boomer Esiason Foundation

Click Here to See All Events & Webinars
Facebook
Twitter
Website
Our mailing address is:
Pacific Research Institute
P.O. Box 60485
Pasadena, CA 91116

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.